The programme is managed by the national QGP committee which is formed from members representing all the main relevant medical, research and education stakeholders in Qatar.

In addition to forming an umbrella for QGP, Qatar Biobank adds great value to the project with its extensive phenotyping including a comprehensive list of biomarkers and various clinical measurements. This adds synergy to the work in terms of the huge wealth of information that can be extracted from the genotype/phenotype association analysis.

The QGP envisages its role as a national platform at which all local stakeholders can meet and contribute to the programme in a way that would make maximum use of resource and prevent duplication of efforts. In addition to Qatar Biobank, QGP is engaged in partnerships with various entities within Hamad Medical Corporation (HMC), Qatar National Research Fund (QNRF), Sidra Medical and Research Center, Qatar Biomedical Research Institute (QBRI), Qatar Computing Research Institute (QCRI), Qatar University, Hamad bin Khalifa University (HBKU), Weil Cornell Medicine-Qatar (WCM-Q) as well as other stakeholders.